It is a preview of subscription content material, log in through an establishment to examine accessibility. Accessibility this chapter First-in-human research of your PARP/tankyrase inhibitor E7449 in individuals with Highly developed solid tumours and analysis of the novel drug-response predictor convey to your doctor and pharmacist For anyone who is https://davida974sxb8.blogspothub.com/profile